The role of STAT3 in effector and memory CD8 T cell longevity and metabolism
The role of STAT3 in effector and memory CD8 T cell longevity and metabolism
批准号:
8226852
负责人:
Susan M Kaech
金额:
$24.87万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-02-01 至 2014-01-31
关键词:
Activities of Daily LivingAcuteAddressAdipocytesAffectAgingAntiviral AgentsAreaAutoimmunityCD8B1 geneCell physiologyCellsCoupledDataDiabetes MellitusEffector CellFatty AcidsGene ExpressionGenerationsGlucoseGlycolysisGrantHeartImmune responseImmunityImmunotherapyInfectionInterleukin-10InvestigationLifeLiverLongevityLymphocyteLymphocytic choriomeningitis virusMalignant NeoplasmsMemoryMetabolicMetabolic ControlMetabolic DiseasesMetabolismMitochondriaMitochondrial ProteinsModelingNeuronsNuclearObesityPI3K/AKTPathway interactionsPhenotypePlayProcessProductionProliferatingProteinsResearchRespirationRestRiskRoleSTAT3 geneSignal TransductionT cell differentiationT memory cellT-Cell DevelopmentT-LymphocyteTransplantationViralVirusVirus DiseasesWorkbasecell typecytokinecytotoxicfatty acid oxidationhuman FRAP1 proteininnovationnovelself-renewalstemtranscription factorvaccine development
中文摘要
描述(由申请人提供):记忆性CD8 T细胞由于其延长的寿命、增殖能力和功能潜力,可以提供异常长期的抗再感染保护性免疫。在病毒感染期间,活化的CD8 T细胞克隆扩增并获得细胞毒功能以消除感染。然而,在病毒被清除后,抗病毒效应CD8 T细胞“休息”下来,停止分裂和合成抗病毒蛋白。一部分效应细胞分化并成熟为保护性记忆CD8 T细胞,这些细胞寿命长,具有高增殖潜力,可以通过稳态增殖补充记忆池。最近的研究表明,这种效应记忆(E 'M)转变需要代谢从主要依赖葡萄糖和糖酵解的合成代谢、快速分裂状态(由PI3K/AKT/mTOR途径驱动)转变为依赖脂肪酸/脂肪酸氧化的分解代谢、静止状态(由Foxo/AMPK活性驱动)。然而,这个模型需要大量的研究,因为我们对记忆CD8 T细胞的代谢状态知之甚少,而CD8 T细胞的代谢状态是调节这一过程的信号,以及这如何影响它们的寿命和功能。也许更重要的是,我们需要更好地了解在免疫反应中CD8 T细胞代谢的变化是如何与T细胞分化协调的。我们假设STAT3位于这两个过程的交叉路口,因为它既是控制记忆T细胞分化的转录因子,又是调节线粒体呼吸的线粒体蛋白。我们的初步数据表明,在急性病毒感染期间,IL-21/IL-10/STAT3信号对于记忆性CD8+ T细胞的发育至关重要。在缺乏IL-21和IL-10或STAT3的情况下,病毒特异性CD8+ T细胞保持终端效应(TE)分化状态,不能成熟为功能记忆T细胞,从而保护细胞免受再感染并包含自我更新的TCM细胞。因此,STAT3活性驱动E - m转化,是急性LCMV感染后形成功能性、保护性记忆性CD8 T细胞所必需的。此外,我们有数据表明STAT3既控制参与记忆性CD8 T细胞分化的关键转录因子的表达,也控制调节记忆性T细胞代谢、分化、功能和存活的PI3K/AKT/mTOR和AMPK通路的活性。这些数据表明STAT3整合了多种信号,并协调调节T细胞分化和代谢。我们的主要目的是确定STAT3是否调节记忆性CD8 T细胞分化过程中的合成代谢“分解代谢开关”。为了研究这一点,我们将确定(1)PI3K/AKT/mTOR活性是否异常升高,反之,Stat3-/-病毒特异性CD8 T细胞中AMPK活性是否降低;(2)Stat3是否控制病毒特异性CD8 T细胞中的糖酵解、氧化呼吸和脂肪酸氧化。最后,我们将(3)比较核和线粒体STAT3在记忆CD8 T细胞发育、代谢和基因表达中的作用。)
英文摘要
DESCRIPTION (provided by applicant): Memory CD8 T cells can provide exceptionally long-term protective immunity against reinfection due to their enhanced longevity, proliferative capacity and functional potential. During a viral infection, the activated CD8 T cells clonally expand and acquire cytotoxic function to eliminate infection. However, after viral clearance, antiviral effector CD8 T cells "rest down" and stop dividing and synthesizing antiviral proteins. A portion of the effector cells differentiate and mature into protective memory CD8 T cells that are long-lived, have a high proliferative potential and can replenish the memory pool by homeostatic proliferation. Recent work suggests that this effector`memory (E`M) transition requires a metabolic switch from an anabolic, rapidly dividing state that relies primarily on glucose and glycolysis (driven by the PI3K/AKT/mTOR pathway) to a catabolic, quiescent state that relies on fatty acids/ fatty acid oxidation (FAO; driven by Foxo/AMPK activity). However, this model requires substantial investigation because very little is known about memory CD8 T cell metabolic states, which signals regulate this process and how this affects their lifespan and function. Perhaps more importantly, we need to better understand how changes in CD8 T cell metabolism are coordinated with T cell differentiation during immune responses. We hypothesize that STAT3 lies at the cross roads of these two processes because it is both a transcription factor that controls memory T cell differentiation and a mitochondrial protein that modulates mitochondrial respiration. Our preliminary data show that IL-21/IL-10/STAT3 signaling is essential for memory CD8+ T cell development during an acute viral infection. In absence of either IL-21 and IL-10 or STAT3, virus-specific CD8+ T cells retain terminal effector (TE) differentiation states and fail to mature into functional memory T cells that protect against reinfection and contain self-renewing TCM cells. Thus, STAT3 activity drives the E`M transition and is necessary for functional, protective memory CD8 T cells to form after acute LCMV infection. Additionally, we have data suggesting that STAT3 controls both the expression of key transcription factors involved in memory CD8 T cell differentiation and the activity of the PI3K/AKT/mTOR and AMPK pathways that regulate memory T cell metabolism, differentiation, function and survival. These data suggest STAT3 integrates various signals and coordinately regulates both T cell differentiation and metabolism. Our primary aim in this proposal is to determine if STAT3 regulates an anabolic ` catabolic switch during memory CD8 T cell differentiation. To study this, we will determine whether (1) PI3K/AKT/mTOR activity is abnormally increased and, reciprocally, if AMPK activity is decreased in Stat3-/- virus-specific CD8 T cells and (2) if STAT3 controls glycolysis, oxidative respiration and fatty acid oxidation in virus-specific CD8 T cells. Lastly, we will (3) compare the roles of nuclear and mitochondrial STAT3 in memory CD8 T cell development, metabolism and gene expression. ) )
PUBLIC HEALTH RELEVANCE: A T cell's metabolic state controls its ability to differentiate, proliferate and survive, and recent elegant studies have suggested that the ability of a memory CD8 T cell to form and persist depends on its ability to switch from an anabolic to catabolic state, utilizing fatty acid oxidation as the major mode of ATP production. This grant will examine the dual roles that STAT3 plays in this process both as a transcription factor and a mitochondrial protein to coordinate the differentiation and metabolism of memory CD8 T cells. This work could uncover multiple novel mechanisms for regulating lymphocyte metabolism and the generation of memory T cells that could enhance vaccine development and T cell based immunotherapies as well as our understanding of diabetes, obesity and aging. )
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Infectious history as a determinant of age-related inflammation in Alzheimers disease
-
批准号:10663042
-
项目类别:
-
资助金额:$19.0万
-
财政年份:2023
-
负责人:Susan M Kaech
-
依托单位:
Core 1: Tumor and Microenvironment Heterogeneity Core (TMH Core)
-
批准号:10629067
-
项目类别:
-
资助金额:$44.26万
-
财政年份:2023
-
负责人:Susan M Kaech
-
依托单位:
Project 3: Chronic interferon and bile acid signaling as drivers of immunosuppression in age-related liver cancer
-
批准号:10270688
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2021
-
负责人:Susan M Kaech
-
依托单位:
Project 3: Chronic interferon and bile acid signaling as drivers of immunosuppression in age-related liver cancer
-
批准号:10698108
-
项目类别:
-
资助金额:$41.16万
-
财政年份:2021
-
负责人:Susan M Kaech
-
依托单位:
Understanding how metabolic heterogeneity in cancer affects the tumor microenvironment and anti-tumor immunity
-
批准号:9981453
-
项目类别:
-
资助金额:$59.93万
-
财政年份:2020
-
负责人:Susan M Kaech
-
依托单位:
Understanding how metabolic heterogeneity in cancer affects the tumor microenvironment and anti-tumor immunity
-
批准号:10570962
-
项目类别:
-
资助金额:$58.73万
-
财政年份:2020
-
负责人:Susan M Kaech
-
依托单位:
Understanding how metabolic heterogeneity in cancer affects the tumor microenvironment and anti-tumor immunity
-
批准号:10335143
-
项目类别:
-
资助金额:$58.73万
-
财政年份:2020
-
负责人:Susan M Kaech
-
依托单位:
Understanding how metabolic heterogeneity in cancer affects the tumor microenvironment and anti-tumor immunity
-
批准号:10747827
-
项目类别:
-
资助金额:$8.11万
-
财政年份:2020
-
负责人:Susan M Kaech
-
依托单位:
Understanding and Overcoming Resistance to Cancer Immunotherapy Due to Defective Antigen Presentation
-
批准号:10337040
-
项目类别:
-
资助金额:$65.55万
-
财政年份:2019
-
负责人:Susan M Kaech
-
依托单位:
Understanding and Overcoming Resistance to Cancer Immunotherapy Due to Defective Antigen Presentation
-
批准号:10559608
-
项目类别:
-
资助金额:$64.2万
-
财政年份:2019
-
负责人:Susan M Kaech
-
依托单位:
(PQ5) Mitochondrial Heterogeneity in Melanoma Tumor and Immune Responses
-
批准号:9900670
-
项目类别:
-
资助金额:$8.05万
-
财政年份:2018
-
负责人:Susan M Kaech
-
依托单位:
(PQ5) Mitochondrial Heterogeneity in Melanoma Tumor and Immune Responses
-
批准号:10471527
-
项目类别:
-
资助金额:$7.95万
-
财政年份:2018
-
负责人:Susan M Kaech
-
依托单位:
(PQ5) Mitochondrial Heterogeneity in Melanoma Tumor and Immune Responses
-
批准号:10248406
-
项目类别:
-
资助金额:$65.1万
-
财政年份:2018
-
负责人:Susan M Kaech
-
依托单位:
(PQ5) Mitochondrial Heterogeneity in Melanoma Tumor and Immune Responses
-
批准号:10471297
-
项目类别:
-
资助金额:$63.8万
-
财政年份:2018
-
负责人:Susan M Kaech
-
依托单位:
Targeting the Immune System in Mouse Models of Lung Adenocarcinoma
-
批准号:8902602
-
项目类别:
-
资助金额:$61.03万
-
财政年份:2015
-
负责人:Susan M Kaech
-
依托单位:
Targeting the Immune System in Mouse Models of Lung Adenocarcinoma
-
批准号:9055670
-
项目类别:
-
资助金额:$59.19万
-
财政年份:2015
-
负责人:Susan M Kaech
-
依托单位:
Regulation of memory CD8 T cell development
-
批准号:8532603
-
项目类别:
-
资助金额:$39.08万
-
财政年份:2013
-
负责人:Susan M Kaech
-
依托单位:
Regulation of memory CD8 T cell development
-
批准号:8997417
-
项目类别:
-
资助金额:$41.63万
-
财政年份:2013
-
负责人:Susan M Kaech
-
依托单位:
Regulation of memory CD8 T cell development
-
批准号:8606806
-
项目类别:
-
资助金额:$41.63万
-
财政年份:2013
-
负责人:Susan M Kaech
-
依托单位:
The role of STAT3 in effector and memory CD8 T cell longevity and metabolism
-
批准号:8415501
-
项目类别:
-
资助金额:$19.54万
-
财政年份:2012
-
负责人:Susan M Kaech
-
依托单位:
海外基金